triiodothyronine has been researched along with Hematologic Malignancies in 2 studies
Triiodothyronine: A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3.
3,3',5-triiodo-L-thyronine : An iodothyronine compound having iodo substituents at the 3-, 3'- and 5-positions. Although some is produced in the thyroid, most of the 3,3',5-triiodo-L-thyronine in the body is generated by mono-deiodination of L-thyroxine in the peripheral tissues. Its metabolic activity is about 3 to 5 times that of L-thyroxine. The sodium salt is used in the treatment of hypothyroidism.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We analyzed the clinical relevance of Low T3 syndrome in COVID-19 patients and, in particular, in those with associated hematological malignancies." | 1.62 | Gene signature and immune cell profiling by high-dimensional, single-cell analysis in COVID-19 patients, presenting Low T3 syndrome and coexistent hematological malignancies. ( Amodeo, R; Anibaldi, P; Ciliberto, G; D'Ascanio, M; De Dominicis, C; de Latouliere, L; De Vitis, C; Di Napoli, A; Fanciulli, M; Giovagnoli, S; Laghi, A; Mancini, R; Napoli, C; Petrucca, A; Piaggio, G; Ricci, A; Sacconi, A; Salerno, G; Salvati, V; Santino, I; Sciacchitano, S; Simmaco, M; Tafuri, A, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sciacchitano, S | 1 |
| De Vitis, C | 1 |
| D'Ascanio, M | 1 |
| Giovagnoli, S | 1 |
| De Dominicis, C | 1 |
| Laghi, A | 1 |
| Anibaldi, P | 1 |
| Petrucca, A | 1 |
| Salerno, G | 1 |
| Santino, I | 1 |
| Amodeo, R | 1 |
| Simmaco, M | 1 |
| Napoli, C | 1 |
| Tafuri, A | 1 |
| Di Napoli, A | 1 |
| Sacconi, A | 1 |
| Salvati, V | 1 |
| Ciliberto, G | 1 |
| Fanciulli, M | 1 |
| Piaggio, G | 1 |
| de Latouliere, L | 1 |
| Ricci, A | 1 |
| Mancini, R | 1 |
| Nellen Hummel, H | 1 |
| Gutiérrez Espíndola, G | 1 |
| Talavera, J | 1 |
| Gordon, F | 1 |
| Halabe, J | 1 |
| Flores, G | 1 |
2 other studies available for triiodothyronine and Hematologic Malignancies
| Article | Year |
|---|---|
Gene signature and immune cell profiling by high-dimensional, single-cell analysis in COVID-19 patients, presenting Low T3 syndrome and coexistent hematological malignancies.
Topics: Aged; Aged, 80 and over; COVID-19; Euthyroid Sick Syndromes; Female; Hematologic Neoplasms; Humans; | 2021 |
Effect of chemotherapy on thyroid hormone concentration in patients with malignant hematologic diseases.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Euthyroid Sick Syndromes; Female; | 1997 |